Regenerative Biomaterials,
Год журнала:
2024,
Номер
12
Опубликована: Дек. 17, 2024
Abstract
Osteoarthritis
(OA)
is
a
frequent
chronic
illness
in
orthopedics
that
poses
major
hazard
to
patient
health.
In
situ
cell
therapy
emerging
as
therapeutic
option,
but
its
efficacy
influenced
by
both
the
inflammatory
milieu
and
amount
of
stem
cells,
limiting
use.
this
study,
we
designed
novel
injectable
porous
microsphere
(PM)
based
on
microfluidic
technology
can
support
mesenchymal
cells
(MSCs)
combining
polylactic–glycolic
acid
copolymer,
kartogenin,
polydopamine,
stromal
cell-derived
factor-1,
copper-doped
bioactive
glass
(CuBG).
The
ex
vivo
tests
demonstrated
PMs@CuBG
microspheres
were
biocompatible
facilitated
transformation
synovial
macrophages
from
pro-inflammatory
M1
anti-inflammatory
M2
phenotypes
releasing
CuBG
reduce
joint
inflammation.
At
same
time,
are
able
recruit
MSCs
into
cavity
encourage
their
differentiation
chondrocytes,
thereby
treating
articular
cartilage
injury.
rat
experimental
results
show
intra-articular
injection
rats
with
OA
improves
OARSI
scores,
aggrecan
content
ratio
col-2α-positive
indicating
reparative
effect
damaged
within
joint.
As
result,
predicted
provide
successful
approach
for
OA.
Abstract
Osteoarthritis
(OA)
is
a
chronic
inflammatory
disease
characterized
by
cartilage
destruction,
synovitis,
and
osteophyte
formation.
Disease‐modifying
treatments
for
OA
are
currently
lacking.
Because
inflammation
mediated
an
imbalance
of
M1/M2
macrophages
in
the
synovial
cavities
contributes
to
progression,
regulating
M1
M2
polarization
can
be
potential
therapeutic
strategy.
Basing
on
inherent
immune
mechanism
pathological
environment
OA,
immunoglobulin
G‐conjugated
bilirubin/JPH203
self‐assembled
nanoparticle
(IgG/BRJ)
developed,
its
evaluated.
After
intra‐articular
administration,
IgG
conjugation
facilitates
recognition
engulfment
nanoparticles
macrophages.
The
internalized
disassemble
response
increased
oxidative
stress,
released
bilirubin
(BR)
JPH203
scavenge
reactive
oxygen
species
(ROS),
inhibit
nuclear
factor
kappa‐B
pathway,
suppress
activated
mammalian
target
rapamycin
result
repolarization
enhance
M2/M1
ratios.
Suppression
IgG/BRJ
promotes
protection
repair
rat
model,
thereby
improving
outcomes.
This
strategy
opsonization
involving
engulf
carrier‐free
BR/JPH203
therapy
holds
great
intervention
treatment.
Advanced Science,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 10, 2025
Abstract
The
infiltration
and
excessive
polarization
of
M1
macrophages
contribute
to
the
induction
persistence
low‐grade
inflammation
in
joint‐related
degenerative
diseases
such
as
osteoarthritis
(OA).
lipid
metabolism
dysregulation
promotes
macrophage
by
coordinating
compensatory
pathways
inflammatory
oxidative
stress
responses.
Here,
a
self‐assembling,
licofelone‐loaded
nanoparticle
(termed
LCF‐CSBN),
comprising
chondroitin
sulfate
bilirubin
joined
an
ethylenediamine
linker,
is
developed
selectively
reprogram
activation.
LCF‐CSBN
internalized
via
CD44‐mediated
endocytosis
targets
Golgi
apparatus
accompanied
with
reactive
oxygen
species‐responsive
release
licofelone
(LCF,
dual
inhibitor
arachidonic
acid
metabolism).
effectively
M2
transition
reprogramming
apparatus‐related
sphingolipid
metabolism.
Intra‐articularly
injected
retains
joint
for
up
28
days
accumulates
into
macrophages.
Moreover,
can
attenuate
inflammation,
stress,
cartilage
degeneration
OA
model
rats.
These
findings
indicate
promising
potential
lipid‐metabolism‐reprogramming
targeted
therapy
OA.
Nano Letters,
Год журнала:
2024,
Номер
24(37), С. 11697 - 11705
Опубликована: Сен. 3, 2024
Osteoarthritis
(OA)
is
a
degenerative
joint
disease
characterized
by
obscure
etiology
and
unsatisfactory
therapeutic
outcomes,
making
the
development
of
new
efficient
therapies
urgent.
Superfluous
reactive
oxygen
species
(ROS)
have
historically
been
considered
one
crucial
factors
inducing
pathological
progression
OA.
Ultrasmall
Prussian
blue
nanoparticles
(USPBNPs),
approximately
sub-5
nm
in
size,
are
developed
regulating
configuration
polyvinylpyrrolidone
chains.
USPBNPs
display
an
excellent
ROS
eliminating
capacity
catalase-like
activity,
capable
decomposing
hydrogen
peroxide
(H
ACS Nano,
Год журнала:
2024,
Номер
18(35), С. 23827 - 23841
Опубликована: Авг. 20, 2024
Carrier-free
nanodrugs
with
extraordinary
active
pharmaceutical
ingredient
(API)
loading
(even
100%),
avoidable
carrier-induced
toxicity,
and
simple
synthetic
procedures
are
considered
as
one
of
the
most
promising
candidates
for
disease
theranostics.
Substantial
studies
commercial
success
"carrier-free"
nanocrystals
have
demonstrated
their
strong
clinical
potential.
However,
practical
translations
remain
challenging
impeded
by
unpredictable
assembly
processes,
insufficient
delivery
efficiency,
an
unclear
in
vivo
fate.
In
this
Perspective,
we
systematically
outline
contemporary
emerging
carrier-free
based
on
diverse
APIs,
well
highlight
opportunities
challenges
translation.
Looking
ahead,
further
improvements
design
preparation,
drug
delivery,
efficacy,
safety
nanomedicines
essential
to
facilitate
translation
from
bench
bedside.
Journal of Advanced Research,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 1, 2025
Acute
lung
injury
(ALI)
is
a
life-threatening
condition
characterized
by
rapidly
progressing
respiratory
distress
and
hypoxemia.
Oxidative
stress-induced
inflammation
in
tissue
plays
crucial
role
the
progression
of
ALI.
Excessive
generation
reactive
oxygen
species
(ROS)
pulmonary
microenvironment
activates
inflammatory
signaling
pathways,
enhancing
transcription
pro-inflammatory
factors
ultimately
leading
to
necrosis.
Bilirubin
(BR),
an
exceptional
endogenous
antioxidant,
possesses
ability
counteract
elevated
levels
through
direct
reactions
or
inducing
antioxidant
systems
such
as
Nrf2/HO-1
signaling.
However,
its
limited
solubility
poses
hindrance
further
applications.
Hence,
it
imperative
develop
suitable
bilirubin-based
system
for
biological
utilization.
In
this
study,
we
developed
ROS-sensitive
adaptive
nanoscavenger
(GP@BR)
co-assembling
bilirubin-conjugated
glycol
chitosan
(GC-BR)
polyethylene
(PEG-BR),
aiming
alleviate
oxidative
stress
ALI
treatment.
The
different
conjugations
endowed
bilirubin
derivatives
with
varying
sensitivity
towards
reacting
ROS,
enabling
GP@BR
exert
antioxidative
properties
specifically
environments
on
demand.
Besides
excellent
properties,
also
demonstrated
absorb
excess
cytokines.
Moreover,
our
optimized
facilitated
transport
across
mucosal
layer
epithelial
cells.
vivo
studies
confirmed
that
significantly
improved
symptoms
suppressed
fibrosis.
This
study
highlighted
potential
multiple
actions
treatment
Journal of Inflammation Research,
Год журнала:
2025,
Номер
Volume 18, С. 4121 - 4142
Опубликована: Март 1, 2025
Osteoarthritis
(OA)
is
a
degenerative
joint
disease
influenced
by
multiple
factors,
with
its
etiology
arising
from
intricate
interactions
among
mechanical
stress,
inflammatory
processes,
and
disruptions
in
bone
metabolism.
Recent
research
immunology
indicates
that
immune-mediated
mechanisms
significantly
contribute
to
the
progression
of
OA,
highlighting
immune
cells,
cytokine
networks,
components.
Immune
cells
interact
osteoclasts,
osteoblasts,
chondrocytes
variety
ways.
These
foster
pro-inflammatory
microenvironment,
contributing
cartilage
breakdown,
synovial
inflammation,
sclerosis
subchondral
bone.
In
this
article,
we
present
comprehensive
review
focusing
on
critical
role
their
cytokine-mediated
feedback
loops
pathophysiology
OA.
addition,
are
exploring
novel
therapeutic
strategies
targeting
pathways,
including
macrophage
polarization,
T-cell
differentiation,
stem
cell
therapy
restore
metabolic
balance
between
immunity
By
integrating
cutting-edge
immunology,
integrates
latest
advancements
construct
framework
for
unraveling
pathogenesis
laying
theoretical
foundation
development
innovative
precision
therapies.
International Journal of Pharmaceutics X,
Год журнала:
2024,
Номер
8, С. 100268 - 100268
Опубликована: Июль 2, 2024
In
assisted
reproduction
techniques,
oocytes
encounter
elevated
levels
of
reactive
oxygen
species
(ROS)
during
in
vitro
maturation
(IVM).
Oxidative
stress
adversely
affects
oocyte
quality,
hampering
their
maturation,
growth,
and
subsequent
development.
Thus,
mitigating
excessive
ROS
to
safeguard
less
viable
IVM
stands
as
a
strategy.
Numerous
antioxidants
have
been
explored
for
IVM,
yielding
considerable
effects;
however,
several
aspects,
including
solubility,
stability,
safety,
demand
attention
resolution.
this
study,
we
developed
nanoparticles
by
self-assembling
endogenous
bilirubin
melatonin
hormone
coated
with
bilirubin-conjugated
glycol
chitosan
(MB@GBn)
alleviate
oxidative
enhance
maturation.
The
optimized
MB@GBn
exhibited
uniform
spherical
shape,
measuring
128
nm
particle
size,
PDI
value
0.1807
surface
potential
+11.35
mV.
positively
charged
facilitated
nanoparticle
adherence
the
through
electrostatic
interaction,
allowing
functional
action.
studies
demonstrated
that
MB@GB
significantly
enhanced
compromised
oocytes.
Further
investigation
revealed
MB@GB's
effectiveness
scavenging
ROS,
reducing
intracellular
calcium
levels,
suppressing
mitochondrial
polarization.
This
study
not
only
offers
novel
perspective
on
nano
drug
delivery
systems
biomedical
applications
but
also
presents
an
innovative
strategy
enhancing
IVM.
Expert Opinion on Drug Delivery,
Год журнала:
2024,
Номер
21(5), С. 735 - 750
Опубликована: Май 3, 2024
Introduction
Epilepsy,
a
prevalent
neurodegenerative
disorder,
profoundly
impacts
the
physical
and
mental
well-being
of
millions
globally.
Historically,
antiseizure
drugs
(ASDs)
have
been
primary
treatment
modality.
However,
despite
introduction
novel
ASDs
in
recent
decades,
significant
proportion
patients
still
experiences
uncontrolled
seizures.